In vitro and in vivo effects of antisense on α2-adrenoceptor expression

Methods in Enzymology

Volumn 314, Issue , 1999, Pages 61-76

  Robinson, Emma S J ^a   Hudson, Alan L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL TISSUE; AUTORADIOGRAPHY; BINDING SITE; BRAIN CORTEX; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; NUCLEIC ACID PROBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; RECEPTOR BLOCKING; REVIEW;

EID: 0032726724     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(99)14095-3     Document Type: Article

References (40)

1. N. French, Pharmacol. Ther. 68, 175 (1995).
2. C. Wahlestedt, E. Golanov, S. Yamamoto, F. Yee, H. Ericson, H. Yoo, C. E. Inturrisi, and D. J. Reis, Nature (London) 363, 260 (1993).
3. C. Wahlestedt, E. Merlo-Pich, G. F. Koob, F. Yee, and M. Heilig, Science 259, 528 (1993).
4. K.-H. Schlingensiepen and M. Heilig, in "Antisense - from Technology to Therapy: Lab Manual and Textbook," p. 187. Blackwell Science, Berlin, 1997.
5. J. Bockaert, V. Homburger, and F. Sladeczek, in "The Pharmacology of Noradrenaline in the Central Nervous System," p. 76. Humana Press, Clifton, New Jersey, 1990.
6. M. A. Reutter, E. M. Richards, and C. Sumners, J. Neurochem. 68, 47 (1997).
7. C. Sumners, W. Tang, B. Zelezna, and M. K. Raizada, Proc. Natl. Acad. Sci. U.S.A. 88, 7567 (1991).
8. A. L. Hudson, N. J. Mallard, R. Tyacke, and D. J. Nutt, Mol. Neuropharmacol. 1, 219 (1992).
9. R. Ishitani and D.-M. Chuang, Proc. Natl. Acad. Sci. U.S.A. 93, 9937 (1996).
10. H. Manev, S. Caredda, and D. R. Grayson, Neuroreport 10, 589 (1991).
11. D. W. Kufe and P. P. Major, Med. Pediatr. Oncol. 10(Suppl.) (1982).
12. Y. Enokido, T. Araki, S. Aizawa, and H. Hatanaka, Neurosci. Lett. 203, 1 (1996).
13. M. Sakeua and B. B. Hoffman, Life Sci. 54, 1785 (1994).
14. J.-C. Devedjian, M. Fargues, C. Denis-Pouxviel, D. Daviaud, H. Prats, and H. Paris, J. Biol. Chem. 266, 14359 (1991).
15. T. Mizobe, K. Maghsoudi, K. Sitwala, G. Tianzhi, J. Ou, and M. Maze, J. Clin. Invest. 98, 1076 (1996).
16. J. C. Hunter, L. R. Fontana, L. R. Hedley, J. R. Jasper, L. Kassotakis, R. Lewis, and R. M. Eglen, Br. J. Pharmacol. 120(Suppl.), 229P (1997).
17. J. C. Hunter, L. R. Fontana, L. R. Hedley, J. R. Jasper, R. Lewis, R. E. Link, R. Secchi, J. Sutton, and R. M. Eglen, Br. J. Pharmacol. 122, 1339 (1997).
18. E. S. J. Robinson and A. L. Hudson, unpublished observation, 1998.
19. E. S. J. Robinson, D. J. Nutt, H. C. Jackson, and A. L. Hudson, J. Psychopharmacol. 11, 259 (1997).
20. J. P. Nunes, Eur. J. Pharmacol. 278, 183 (1995).
21. B. Weiss, G. Davidkova, and S.-P. Zhang, Neurochem. Int. 31, 321 (1997).
22. Z.-H. Qin, L.-W. Zhou, S.-P. Zhang, Y. Wang, and B. Weiss, Mol. Pharmacol. 48, 730 (1995).
23. C. H. Adler, E. Meller, and M. Goldstein, Eur. J. Pharmacol. 116, 175 (1985).
24. M. J. Durcan, P. F. Morgan, M. L. Van Etten, and M. Linnoila, Br. J. Pharmacol. 112, 855 (1994).
25. J. Pineda, J. A. Ruiz-Ortega, and L. Ugedo, J. Pharmacol. Exp. Ther. 281, 690 (1997).
26. R. M. McKernan and I. C. Campbell, Eur. J. Pharmacol. 80, 279 (1982).
27. R. M. McKernan, W. R. Strickland, and P. A. Insel, Mol. Pharmacol. 33, 51 (1987).
28. L.-W. Zhou, S.-P. Zhang, Z.-H. Qin, and B. Weiss, J. Pharmacol. Exp. Ther. 268, 1015 (1994).
29. Y. Yaida and T. S. Nowak, Regul. Peptides 59, 193 (1995).
30. B. Schöbitz, G. Pezeshli, C. P. Probst, M. H. M. Reul, T. Skutella, T. Stöhr, F. Holsboer, and R. Spanagel, Eur. J. Pharmacol. 331, 97 (1997).
31. S. M. Le Corre, P. W. J. Burnet, R. Meller, T. Sharp, and P. J. Harrison, Neurochem. Int. 31, 349 (1997).
32. A. Bourson, E. Borroni, R. H. Austin, J. Monsma, Jr., and A. J. Sleight, J. Pharmacol. Exp. Ther. 274, 173 (1995).
33. J. Georgieva, M. Heilig, I. Nylander, M. Herrero-Marschitz, and L. Terenius, Neurosci. Lett. 192, 69 (1995).
34. R. Landgraf, R. Gerstberger, A. Montkowski, J. C. Probst, C. T. Wotjak, F. Holsboer, and M. Engelmann, J. Neurosci. 15, 4250 (1995).
35. B. J. Chiasson, J. N. Armstrong, M. L. Hooper, P. R. Murphey, and H. A. Robertson, Cell. Mol. Neurobiol. 14, 507 (1994).
36. T. M. Woolf, C. G. Jennings, M. Rebagliati, and D. Melton, Nucleic Acids Res. 18, 1763 (1990).
37. T. M. Woolf, D. A. Melton, and C. G. B. Jennings, Proc. Natl. Acad. Sci. U.S.A. 89, 7305 (1992).
38. S. T. Cooke, Annu. Rev. Pharmacol. Toxicol. 32, 329 (1992).
39. O. Heidenreich, S.-H. Kang, X. Xu, and N. Nerenberg, Mol. Med. Today 1, 128 (1995).
40. C. A. Stein, Nature Med. 1, 1119 (1995).